Dr. Joshua H. Bilenker

Dr. Joshua H. Bilenker, founder of Loxo Oncology, Inc., has served as Loxo’s President and Chief Executive Officer since July 2013. Dr. Bilenker joined Aisling Capital LLC, an investment firm, in April 2006 and has served as an Operating Partner since November 2013.  From 2004 to 2006, Dr. Bilenker served as a Medical Officer at the FDA in the Office of Oncology. Dr. Bilenker trained at the University of Pennsylvania in internal medicine and medical oncology, earning board certification in these specialties. He received his M.D. from The Johns Hopkins School of Medicine and his A.B. degree in English from Princeton University